Skip to main content
Glama

Vies Eu

by io.github.pipeworx-io

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.6/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already mark the tool read-only, open-world, idempotent, and non-destructive. The description adds substantial behavioral detail beyond those hints: graceful degradation when GLEIF/OpenFIGI are unavailable, cascading through multiple lookup endpoints, explicit `unresolved` fields, `figi_candidates` on ambiguity, source labeling, and ISIN-to-LEI mapping for non-US issuers. No contradiction exists with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is dense and long, but the complexity of the tool justifies most of the length. It front-loads the trigger phrases and 'Use FIRST' guidance, then organizes type-specific behavior under SUPPORTED TYPES. Minor redundancy and heavy parenthetical asides keep it one step below maximal conciseness.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description carries the full burden of explaining return behavior, and it does so thoroughly: resolved identifiers, source attribution, unresolved identifiers, candidate results for ambiguous matches, parent/ultimate-parent ownership, and graceful failure modes. Given the tool's complexity, the description is complete enough for an agent to know what to expect and how to invoke it correctly.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% and the schema already documents `type` and `value` well. The description adds value by clarifying accepted input forms (ticker, CIK, ISIN, name), warning against full noun phrases for bond issuer lookups, and explaining type-specific resolution behavior. This goes beyond the baseline for fully covered schemas, though some parameter guidance is redundant with the schema's own description.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

Description states a specific action: resolve user-spoken names to canonical identifiers other tools require. It provides concrete query examples and enumerates supported entity types, clearly distinguishing this tool from lookups by ticker/CIK/ISIN/name. The phrasing 'Use FIRST whenever you have a name but need an ID' makes the tool's role and scope explicit even among many siblings.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives explicit triggering conditions: use it when the user supplies a name and the agent needs an official identifier, and it covers both company and drug cases. It does not explicitly name alternatives like entity_profile or compare_entities or state when not to use this tool, but its 'Use FIRST whenever...' guidance and supported-type list give clear context for invocation.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Vies Eu toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.8/5.0
Disambiguation2/5

Multiple tools have heavily overlapping purposes: ask_pipeworx, ask_pipeworx_beta (explicitly identical to the stable router right now), ask_pipeworx_grounded, and deep_research all route the same class of questions, making mis-selection easy. The six Polymarket tools (bet_research, polymarket_arbitrage, polymarket_edges, polymarket_edge_tracker, polymarket_fill_risk, polymarket_kalshi_spread) also blur together around edge detection and arbitrage, further muddying tool boundaries.

Naming Consistency4/5

All 33 tools use consistent lowercase snake_case naming, and most follow a clear verb_noun pattern (check_vat, compare_entities, resolve_entity, unsubscribe). A handful of noun-style names (entity_profile, bet_research, polymarket_edges, recent_alerts) deviate from the verb-first pattern but are still predictable and readable.

Tool Count2/5

33 tools is beyond the 25+ threshold for a coherent set, and the scope is sprawling: universal data routing, prediction-market analytics, VAT validation, AI visibility, memory, subscriptions, npm dependency scanning, and feedback. While each sub-domain has reason to exist, bundling them all into one server creates a kitchen-sink feel with too many entry points.

Completeness3/5

The core data-routing domain is well covered: universal router, grounded mode, deep research, entity resolution, profiles, comparisons, change feeds, claim validation, and search-within. VAT has check + status, and memory/subscription lifecycles are complete. However, there is no standalone tool to fetch a raw pipeworx:// record that citations reference, and the extreme breadth means no single domain is exhaustively fleshed out.

Resources